Home ETF List About

Portfolio Holdings Detail for ISIN IE000MLMNYS0
Stock Name / FundiShares S&P 500 Equal Weight UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerEWSP.AS(USD) CXE
ETF TickerEWSP.LS(GBP) CXE
ETF TickerEWSP.MI(EUR) CXE
ETF TickerEWSP(EUR) ETF Plus

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares S&P 500 Equal Weight UCITS ETF USD (Acc) LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-09-25 (Thursday)12,153LLY holding increased by 91USD 8,684,412LLY holding decreased by -263783USD 8,684,41291USD -263,783 USD 714.59 USD 741.85
2025-09-24 (Wednesday)12,062USD 8,948,195USD 8,948,195
2025-09-18 (Thursday)10,836LLY holding increased by 12USD 8,267,109LLY holding increased by 39462USD 8,267,10912USD 39,462 USD 762.93 USD 760.13
2025-09-17 (Wednesday)10,824USD 8,227,647LLY holding decreased by -49574USD 8,227,6470USD -49,574 USD 760.13 USD 764.71
2025-09-16 (Tuesday)10,824USD 8,277,221LLY holding increased by 178812USD 8,277,2210USD 178,812 USD 764.71 USD 748.19
2025-09-15 (Monday)10,824USD 8,098,409LLY holding decreased by -77932USD 8,098,4090USD -77,932 USD 748.19 USD 755.39
2025-09-12 (Friday)10,824USD 8,176,341LLY holding decreased by -9634USD 8,176,3410USD -9,634 USD 755.39 USD 756.28
2025-09-11 (Thursday)10,824USD 8,185,975LLY holding increased by 17968USD 8,185,9750USD 17,968 USD 756.28 USD 754.62
2025-09-10 (Wednesday)10,824LLY holding decreased by -6USD 8,168,007LLY holding increased by 38901USD 8,168,007-6USD 38,901 USD 754.62 USD 750.61
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE000MLMNYS0

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-25BUY91 714.590* 798.60
2025-09-18BUY12 762.930* 798.78
2025-09-10SELL-6 754.620* 800.10 Profit of 4,801 on sale
2025-09-08SELL-6 738.640* 800.68 Profit of 4,804 on sale
2025-09-02BUY18 735.190* 801.03
2025-08-21BUY12 709.820* 801.51
2025-08-19BUY12 703.210* 802.56
2025-07-29BUY7 762.950* 803.91
2025-07-23SELL-18 798.890* 803.88 Profit of 14,470 on sale
2025-07-22SELL-36 776.440* 804.03 Profit of 28,945 on sale
2025-07-21SELL-12 762.180* 804.27 Profit of 9,651 on sale
2025-07-11SELL-18 793.010* 804.33 Profit of 14,478 on sale
2025-07-10SELL-72 790.650* 804.41 Profit of 57,918 on sale
2025-07-09SELL-24 786.920* 804.51 Profit of 19,308 on sale
2025-07-08SELL-78 777.660* 804.67 Profit of 62,764 on sale
2025-07-03SELL-102 780.670* 805.14 Profit of 82,124 on sale
2025-07-02SELL-18 779.280* 805.29 Profit of 14,495 on sale
2025-06-27SELL-294 775.450* 805.62 Profit of 236,853 on sale
2025-06-25BUY6 792.300* 805.77
2025-06-24SELL-222 778.080* 805.93 Profit of 178,917 on sale
2025-06-18SELL-36 785.030* 806.19 Profit of 29,023 on sale
2025-06-17SELL-66 791.240* 806.29 Profit of 53,215 on sale
2025-06-11SELL-18 808.610* 806.14 Profit of 14,511 on sale
2025-06-10SELL-42 807.190* 806.14 Profit of 33,858 on sale
2025-06-06SELL-12 769.880* 806.58 Profit of 9,679 on sale
2025-06-05SELL-102 765.680* 806.85 Profit of 82,299 on sale
2025-06-02SELL-486 747.120* 807.89 Profit of 392,637 on sale
2025-05-30SELL-108 737.670* 808.37 Profit of 87,304 on sale
2025-05-29SELL-12 722.570* 808.95 Profit of 9,707 on sale
2025-05-27SELL-12 725.220* 810.13 Profit of 9,722 on sale
2025-05-23SELL-18 713.710* 811.47 Profit of 14,606 on sale
2025-05-16SELL-90 757.390* 814.05 Profit of 73,264 on sale
2025-05-15SELL-18 733.290* 814.63 Profit of 14,663 on sale
2025-05-13SELL-6 746.060* 815.86 Profit of 4,895 on sale
2025-05-12SELL-42 755.570* 816.31 Profit of 34,285 on sale
2025-05-09SELL-36 734.570* 816.92 Profit of 29,409 on sale
2025-05-08SELL-174 751.450* 817.41 Profit of 142,230 on sale
2025-05-07SELL-12 776.720* 817.72 Profit of 9,813 on sale
2025-05-06BUY8 775.120* 818.05
2025-05-01BUY228 794.100* 818.16
2025-04-30BUY126 898.950* 817.53
2025-04-29SELL-24 885.200* 816.99 Profit of 19,608 on sale
2025-04-28BUY254 877.290* 816.51
2025-04-25BUY12 884.540* 815.96
2025-04-24SELL-6 859.730* 815.60 Profit of 4,894 on sale
2025-04-22SELL-804 827.540* 815.39 Profit of 655,573 on sale
2025-04-17SELL-366 839.960* 814.95 Profit of 298,272 on sale
2025-04-16BUY12 734.900* 815.63
2025-04-15BUY12 757.180* 816.14
2025-04-10SELL-378 720.910* 818.27 Profit of 309,306 on sale
2025-04-09BUY30 753.710* 818.85
2025-04-08BUY6 726.240* 819.68
2025-04-07BUY108 723.730* 820.55
2025-04-04BUY66 738.210* 821.31
2025-04-02BUY42 818.220* 821.34
2025-04-01BUY474 805.230* 821.49
2025-03-31BUY18 825.910* 821.44
2025-03-25BUY6 852.350* 821.08
2025-03-21SELL-1,527 837.570* 820.47 Profit of 1,252,863 on sale
2025-03-20BUY14 842.570* 820.25
2025-03-18BUY35 822.510* 820.05
2025-03-17BUY7 824.760* 820.01
2025-03-13SELL-420 801.650* 820.27 Profit of 344,513 on sale
2025-03-12BUY84 821.860* 820.25
2025-03-11BUY84 824.060* 820.21
2025-03-07BUY28 869.580* 819.56
2025-03-06BUY98 912.760* 818.51
2025-03-05BUY532 929.720* 817.25
2025-03-04BUY28 911.060* 816.17
2025-03-03BUY35 929.720* 814.85
2025-02-28BUY70 920.630* 813.60
2025-02-27BUY63 905.160* 812.51
2025-02-26SELL-35 915.010* 811.28 Profit of 28,395 on sale
2025-02-25SELL-7 901.800* 810.17 Profit of 5,671 on sale
2025-02-24BUY7 881.400* 809.29
2025-02-20SELL-91 873.120* 807.67 Profit of 73,498 on sale
2025-02-19BUY28 867.050* 806.91
2025-02-18BUY28 857.200* 806.26
2025-02-13BUY798 871.860* 804.34
2025-02-12BUY238 872.970* 803.40
2025-02-11BUY196 865.000* 802.55
2025-02-07BUY21 878.310* 800.52
2025-02-06BUY280 870.370* 799.51
2025-02-05BUY140 842.180* 798.88
2025-02-04BUY105 826.070* 798.47
2025-02-03SELL-609 810.430* 798.29 Profit of 486,159 on sale
2025-01-31BUY56 811.080* 798.09
2025-01-30BUY7 823.230* 797.70
2025-01-29BUY119 804.080* 797.60
2025-01-28BUY42 804.990* 797.48
2025-01-27BUY42 808.170* 797.31
2025-01-24BUY42 785.410* 797.50
2025-01-23BUY119 766.600* 798.03
2025-01-22BUY70 753.980* 798.79
2025-01-21BUY413 742.350* 799.78
2025-01-17BUY84 725.720* 802.47
2025-01-15BUY42 746.740* 804.37
2025-01-13BUY119 797.480* 805.67
2025-01-10BUY91 799.900* 805.79
2024-12-31BUY21 772.000* 807.93
2024-12-30BUY28 773.840* 808.69
2024-12-27BUY133 783.170* 809.27
2024-12-23BUY36 796.280* 810.28
2024-12-20BUY2,224 767.760* 811.35
2024-12-19BUY60 757.540* 812.73
2024-12-17BUY45 778.620* 814.95
2024-12-16BUY15 779.000* 815.95
2024-12-13BUY25 789.120* 816.71
2024-12-11BUY15 796.030* 817.32
2024-12-10BUY10 799.580* 817.86
2024-12-09BUY10 803.580* 818.30
2024-12-05SELL-30 825.620* 817.78 Profit of 24,533 on sale
2024-12-04BUY5 829.840* 817.36
2024-12-02BUY20 799.800* 818.16
2024-11-29BUY90 795.350* 819.04
2024-11-27BUY20 788.190* 821.61
2024-11-26BUY50 789.320* 823.02
2024-11-25BUY620 755.000* 826.11
2024-11-22BUY15 748.010* 829.83
2024-11-21BUY15 749.920* 833.82
2024-11-20BUY65 753.410* 838.05
2024-11-19SELL-65 729.730* 844.07 Profit of 54,865 on sale
2024-11-18BUY300 727.200* 850.95
2024-11-12BUY60 818.860* 852.95
2024-11-11BUY15 832.440* 854.32
2024-11-08BUY61 831.540* 855.95
2024-11-07BUY106 797.450* 860.45
2024-11-06BUY45 776.380* 867.45
2024-11-05BUY10 806.060* 873.03
2024-11-04BUY55 806.140* 879.72
2024-11-01BUY25 818.930* 886.48
2024-10-31SELL-201 829.740* 893.57 Profit of 179,607 on sale
2024-10-30BUY15 846.830* 900.25
2024-10-29BUY95 903.580* 899.69
2024-10-25BUY20 892.700* 902.46
2024-10-24BUY15 891.320* 906.18
2024-10-22BUY30 909.150* 906.13
2024-10-21BUY25 906.130* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.